Entera Bio annual ebitda
2016
2017
2018
2019
2020
Entera Bio EBITDA Growth & History (ENTX)
Entera Bio's calculated EBITDA was −$10.9M for fiscal 2020.
View full Entera Bio company overviewEntera Bio annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | −$10.9M | $273,000 | — |
| 2019 | 2019-12-31 | −$11.2M | −$409,000 | — |
| 2018 | 2018-12-31 | −$10.8M | $493,000 | — |
| 2017 | 2017-12-31 | −$11.3M | −$6.0M | — |
| 2016 | 2016-12-31 | −$5.3M | — | — |
Entera Bio quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Entera Bio ebitda trends
Across the available reported history, Entera Bio's ebitda increased from −$11.2M to −$10.9M, a change of $273,000.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio filings at SEC.gov ↗